India to South Africa: Erlotinib Export Trade Route
India has recorded 2 verified shipments of Erlotinib exported to South Africa, representing a combined trade value of $78.8K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $39.4K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 100% of total export value with 2 shipments worth $78.8K USD. On the buying side, MEDPRO PHARMACEUTICA (PTY) LTD, is the largest importer in South Africa with $78.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Africa Erlotinib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $78.8K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $39.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with erlotinib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 22.0%, placing it at rank #14 among India's top erlotinib export destinations globally.
On the import side, key buyers of Indian erlotinib in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD,. MEDPRO PHARMACEUTICA (PTY) LTD, is the single largest importer with 2 shipments valued at $78.8K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#14
- Annual growth+22.0%
- Demand growth+20.5%
- Regulatory ease77/100
Top 10 Indian Erlotinib Exporters to South Africa
Showing top 10 of 1 Indian suppliers exporting Erlotinib to South Africa, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $39.4K per shipment | 2 | $78.8K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting erlotinib to South Africa, ranked by total trade value. The listed exporters are: CIPLA LIMITED. CIPLA LIMITED is the dominant supplier with 2 shipments worth $78.8K USD, giving it a 100% market share.
Top 10 Erlotinib Importers in South Africa
Showing top 10 of 1 known buyers in South Africa receiving Erlotinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erlotinib in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD,. The largest importer is MEDPRO PHARMACEUTICA (PTY) LTD,, accounting for $78.8K USD across 2 shipments — representing 100% of all erlotinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA (PTY) LTD, | 2 | $78.8K | 100.0% |
Top 10 Erlotinib Formulations Imported by South Africa
Showing top 10 of 2 product formulations shipped on the India to South Africa Erlotinib route, ranked by trade value
South Africa imports a wide range of erlotinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERLOCIP 150 TABLET (ERLOTINIB 150MG) (25 — accounts for $59.9K USD across 1 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERLOCIP 150 TABLET (ERLOTINIB 150MG) (25 | 1 | $59.9K | 76.0% |
| 2 | ERLOCIP 100 TABLET (ERLOTINIB 100MG) (10 | 1 | $18.9K | 24.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 2 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's erlotinib exports to South Africa are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $39.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as erlocip 100 tablet (erlotinib 100mg) (10, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MEDPRO PHARMACEUTICA (PTY) LTD, is the largest importer with 2 shipments worth $78.8K USD — representing 100% of all erlotinib imports from India on this route.
Route Statistics
- Trade Volume
- $78.8K
- Avg. Shipment
- $39.4K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~24 days
- Annual Growth
- +22.0%
Other Erlotinib Routes
Unlock the Full India to South Africa Erlotinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2 shipments on this route.
Frequently Asked Questions — India to South Africa Erlotinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erlotinib to South Africa?
The leading Indian exporters of Erlotinib to South Africa are CIPLA LIMITED. CIPLA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Erlotinib exports from India to South Africa?
India exports Erlotinib to South Africa worth approximately $78.8K USD across 2 recorded shipments. The average value per shipment is $39.4K USD.
Q Which ports does India use to ship Erlotinib to South Africa?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 2 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to South Africa for Erlotinib?
The average transit time for Erlotinib shipments from India to South Africa is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to South Africa Erlotinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.0% with demand growth tracking at 20.5%. The route is ranked #14 among India's top Erlotinib export destinations globally.
Q How many suppliers are active on the India to South Africa Erlotinib route?
There are currently 1 active Indian suppliers exporting Erlotinib to South Africa. The market is moderately concentrated with CIPLA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Erlotinib from India in South Africa?
The leading importers of Indian Erlotinib in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD,. MEDPRO PHARMACEUTICA (PTY) LTD, is the largest buyer with 2 shipments worth $78.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to South Africa export trade corridor identified from Indian Customs (DGFT) records for Erlotinib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in South Africa matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists